Drug utilization study on immediate release Fentanyl in Spain. Prevalence, incidence, and indication.

Diana González-BermejoPilar Rayón-IglesiasAlfonso Rodríguez-PascualArturo Álvarez-GutiérrezAna Fernández-DueñasDolores Montero-CorominasConsuelo Huerta-Álvarez

Published in: Pharmacoepidemiology and drug safety (2020)

National consumption and new IRF users in Spain increased over the study period and one quarter of patients did not have a BTCP or cancer diagnosis registered in their clinical record.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
squamous cell carcinoma
dendritic cells
prognostic factors
quality improvement
patient reported outcomes
drug induced